FDA Rejects Rocket Pharmaceuticals' Gene Therapy For Rare Immune Disorder, Asks For More Data, Stock Slides
Express News | Trading Halt: Halt Status Updated at 8:00:00 AM ET: Quotation Resumption: News and Resumption Times
Rocket Pharmaceuticals Provides Regulatory Update on KRESLADI (Marnetegragene Autotemcel; Marne-cel)
Express News | Trading Halt: Halted at 6:56:37 A.m. ET - Trading Halt: Halt News Pending
Rocket Pharmaceuticals (NASDAQ:RCKT) Is In A Good Position To Deliver On Growth Plans
Rocket Pharmaceuticals Presents Positive Data From LV Hematology Portfolio at the 27th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT)
10-Q: Quarterly report
Form 144 | Rocket Pharmaceuticals(RCKT.US) Director Proposes to Sell 240.52K in Common Stocks
SEC FILLINGS DISCLOSED/ Apr 15, $Rocket Pharmaceuticals(RCKT.US)$、$ROCKET PHARMACEUTICALS INC C/WTS 02/09/2026 (TO PUR COM)(RCKTW.US)$ Director SOUTHWELL DAVID P intends to sell 10,000 shares of its c
Form 144 | Rocket Pharmaceuticals(RCKT.US) Director Proposes to Sell 1.71 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Apr 12, $Rocket Pharmaceuticals(RCKT.US)$、$ROCKET PHARMACEUTICALS INC C/WTS 02/09/2026 (TO PUR COM)(RCKTW.US)$ Director SOUTHWELL DAVID P intends to sell 70,000 shares of its c
Rocket Pharmaceuticals Announces Appointment of Aaron Ondrey as Chief Financial Officer and Additional Updates to Corporate Leadership Team
Rocket Pharmaceuticals, Inc.'s (NASDAQ:RCKT) Shift From Loss To Profit
No Data